Technical Stock Pick: Should you buy this FY24 multibagger pharma stock after recent dip?

Aurobindo Pharma’s stock, after a 100% rally in FY24, faced resistance but is now showing signs of bottoming out. Experts suggest a possible rise above Rs 1,300 for short-term traders.

More To Explore